Augmedix Inc AUGX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AUGX is a good fit for your portfolio.
News
-
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
-
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024
-
Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List
-
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
-
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
-
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
-
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
-
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
Trading Information
- Previous Close Price
- $2.66
- Day Range
- $2.66–2.73
- 52-Week Range
- $2.50–6.25
- Bid/Ask
- $1.50 / $2.78
- Market Cap
- $132.70 Mil
- Volume/Avg
- 242,897 / 372,500
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.66
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,430
- Website
- https://www.augmedix.com
Comparables
Valuation
|
Metric
|
AUGX
|
LFST
|
NBLY
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 37.89 |
Price/Book Value | 5.65 | 1.77 | 1.42 |
Price/Sales | 2.66 | 2.32 | 0.95 |
Price/Cash Flow | — | 145.33 | 13.98 |
Price/Earnings
AUGX
LFST
NBLY
Financial Strength
|
Metric
|
AUGX
|
LFST
|
NBLY
|
|---|---|---|---|
Quick Ratio | 2.32 | 1.01 | 0.40 |
Current Ratio | 2.41 | 1.11 | 1.14 |
Interest Coverage | −7.94 | −8.74 | −0.27 |
Quick Ratio
AUGX
LFST
NBLY
Profitability
|
Metric
|
AUGX
|
LFST
|
NBLY
|
|---|---|---|---|
Return on Assets (Normalized) | −39.03% | −4.64% | −1.59% |
Return on Equity (Normalized) | −323.42% | −6.76% | −2.93% |
Return on Invested Capital (Normalized) | −58.02% | −4.11% | 0.86% |
Return on Assets
AUGX
LFST
NBLY
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Zgpldvy | $36.3 Bil | |
VEEV
| Veeva Systems Inc Class A | Zcxwktzrly | Nhnh | $32.9 Bil | |
SOLV
| Solventum Corp | — | Wygmrf | $11.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Yjythzf | $7.8 Bil | |
MTHRF
| M3 Inc | — | Yhqtlxz | $7.3 Bil | |
MTHRY
| M3 Inc ADR | — | Gpsjpz | $7.3 Bil | |
HQY
| HealthEquity Inc | — | Brswry | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Bdvp | $5.2 Bil | |
DOCS
| Doximity Inc Class A | — | Pchfsgw | $4.5 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Zsyg | $3.3 Bil |